Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Eton Pharmaceuticals, Inc.ETON · Entity 4598 | Director | March 12, 2020 | March 16, 2020 |
| HARROW, INC.HROW · Entity 4740 | Director · CHIEF EXECUTIVE OFFICER | May 14, 2026 | May 15, 2026 |
| Ideal Power Inc.IPWR · Entity 6940 | Director | March 03, 2017 | March 06, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Eton Pharmaceuticals, Inc.
Report date March 12, 2020 · Filed March 16, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.58 · Expires 2030-03-11 | Direct | 27,400 |
Reported balance
After 2020-03-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-03-12 · Grant · Acquired 27,400 · Balance 27,400 F1: The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on March 12, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on March 12, 2021.
HARROW, INC.
Report date May 14, 2026 · Filed May 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,996,130 |
Reported balance
After 2026-05-14 transaction · row 1
1 source rowRow 1 · 2026-05-14 · Purchase · Acquired 10,000 · Balance 2,996,130 F1: The price reported in Column 4 is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $30.18 to $30.34, inclusive. The reporting person undertakes to provide to Harrow, Inc., any security holder of Harrow, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $30.18 to $30.34, inclusive. The reporting person undertakes to provide to Harrow, Inc., any security holder of Harrow, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Ideal Power Inc.
Report date March 03, 2017 · Filed March 06, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 33,698 |
Reported balance
After 2017-03-03 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2017-03-03 · Purchase · Acquired 7,800 · Balance 33,698 F1: The reported securities are included within the securities purchased by the reporting person for $2.535 per share of common stock together with a warrant to purchase one share of common stock. F2: The securities are owned by Beadore Trust dated March 20, 2015. The reporting person has voting and investment control over the securities. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 29,063 |
Reported balance
Holding disclosure · report date 2017-03-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 29,063 F2: The securities are owned by Beadore Trust dated March 20, 2015. The reporting person has voting and investment control over the securities. |
| Common Stock WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $2.41 · Expires 2020-03-03 | IndirectSee Footnote | 7,800 |
Reported balance
After 2017-03-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-03-03 · Purchase · Acquired 7,800 · Balance 7,800 F1: The reported securities are included within the securities purchased by the reporting person for $2.535 per share of common stock together with a warrant to purchase one share of common stock. F2: The securities are owned by Beadore Trust dated March 20, 2015. The reporting person has voting and investment control over the securities. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities are included within the securities purchased by the reporting person for $2.535 per share of common stock together with a warrant to purchase one share of common stock.
F2: The securities are owned by Beadore Trust dated March 20, 2015. The reporting person has voting and investment control over the securities.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2026 Filed May 15, 2026 11:01 UTC | HARROW, INC. HROW · Entity 4740 | PurchaseCommon Stock | 10,000 | $30.20 | $302,000.00 |
DisclosureSEC source: 0001493152-26-023321 · ownership.xml · nonDerivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,996,130 F1 · price: The price reported in Column 4 is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $30.18 to $30.34, inclusive. The reporting person undertakes to provide to Harrow, Inc., any security holder of Harrow, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 12, 2025 Filed Dec 17, 2025 01:48 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionStock Option (Right to Buy) · Derivative | 180,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001493152-25-028036 · ownership.xml · derivative · entry 3 BAUM MARK L · CIK 0001274282 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 180,000 shares Expires 2026-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents stock options granted to Mr. Baum on April 1, 2016 under the Issuer's 2007 Stock Incentive and Awards Plan, as amended. The stock options vested quarterly over a three-year period following the grant date. 79,994 shares were withheld to satisfy the exercise price and tax liability incident to the exercise of the stock option. Such withholding did not involve any market sales or other market transactions. F1 · derivative.exercise_date: Represents stock options granted to Mr. Baum on April 1, 2016 under the Issuer's 2007 Stock Incentive and Awards Plan, as amended. The stock options vested quarterly over a three-year period following the grant date. 79,994 shares were withheld to satisfy the exercise price and tax liability incident to the exercise of the stock option. Such withholding did not involve any market sales or other market transactions. Read SEC document |
| December 12, 2025 Filed Dec 17, 2025 01:48 UTC | HARROW, INC. HROW · Entity 4740 | Tax withholdingCommon Stock | 79,994 | $47.06 | $3,764,517.64 |
DisclosureSEC source: 0001493152-25-028036 · ownership.xml · nonDerivative · entry 2 BAUM MARK L · CIK 0001274282 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,986,130 Read SEC document |
| December 12, 2025 Filed Dec 17, 2025 01:48 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionCommon Stock | 180,000 | $3.95 | $711,000.00 |
DisclosureSEC source: 0001493152-25-028036 · ownership.xml · nonDerivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,066,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2025 Filed Jul 24, 2025 01:10 UTC | HARROW, INC. HROW · Entity 4740 | Tax withholdingCommon stock | 313,338 | $37.08 | $11,618,573.04 |
DisclosureSEC source: 0001641172-25-020751 · ownership.xml · nonDerivative · entry 2 BAUM MARK L · CIK 0001274282 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,886,124 Read SEC document |
| July 21, 2025 Filed Jul 24, 2025 01:10 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionCommon stock | 600,000 | $7.87 | $4,722,000.00 |
DisclosureSEC source: 0001641172-25-020751 · ownership.xml · nonDerivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · CHIEF EXECUTIVE OFFICER · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,199,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2025 Filed Jul 1, 2025 20:45 UTC | HARROW, INC. HROW · Entity 4740 | GrantRSU · Derivative | 889,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-017376 · ownership.xml · derivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 889,500 Underlying: Common Stock · 889,500 shares Expires not disclosed F1 · security: Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2025 Stock Incentive and Awards Plan, (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. The vesting of the PSUs (granted in lieu of service only stock option and restricted stock unit awards) require (i) a minimum of a three-year service period, and (ii) the achievement and maintenance of Harrow common stock price targets of $50 (causing the vesting of 124,530 PSU shares), $60 (causing the vesting of 186,795 PSU shares), $75 (causing the vesting of 257,955 PSU shares), $100 (causing the vesting of 320,220 PSU shares). F1 · derivative.exercise_price: Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2025 Stock Incentive and Awards Plan, (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. The vesting of the PSUs (granted in lieu of service only stock option and restricted stock unit awards) require (i) a minimum of a three-year service period, and (ii) the achievement and maintenance of Harrow common stock price targets of $50 (causing the vesting of 124,530 PSU shares), $60 (causing the vesting of 186,795 PSU shares), $75 (causing the vesting of 257,955 PSU shares), $100 (causing the vesting of 320,220 PSU shares). F1 · derivative.exercise_date: Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2025 Stock Incentive and Awards Plan, (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. The vesting of the PSUs (granted in lieu of service only stock option and restricted stock unit awards) require (i) a minimum of a three-year service period, and (ii) the achievement and maintenance of Harrow common stock price targets of $50 (causing the vesting of 124,530 PSU shares), $60 (causing the vesting of 186,795 PSU shares), $75 (causing the vesting of 257,955 PSU shares), $100 (causing the vesting of 320,220 PSU shares). F1 · derivative.expiration_date: Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2025 Stock Incentive and Awards Plan, (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. The vesting of the PSUs (granted in lieu of service only stock option and restricted stock unit awards) require (i) a minimum of a three-year service period, and (ii) the achievement and maintenance of Harrow common stock price targets of $50 (causing the vesting of 124,530 PSU shares), $60 (causing the vesting of 186,795 PSU shares), $75 (causing the vesting of 257,955 PSU shares), $100 (causing the vesting of 320,220 PSU shares). Read SEC document |
| April 07, 2025 Filed Apr 8, 2025 01:54 UTC | HARROW, INC. HROW · Entity 4740 | Tax withholdingCommon Stock | 300,363 | $23.09 | $6,935,381.67 |
DisclosureSEC source: 0001641172-25-003109 · ownership.xml · nonDerivative · entry 2 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,599,462 F1 · shares: The 762,300 shares of Harrow, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares upon vesting of performance stock units ("PSUs") granted to Mr. Baum under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on April 3, 2023. The PSUs vested on April 3, 2025 and were settled in full in shares of Harrow common stock (on a one-for-one basis) on April 7, 2025, following attainment of (i) a two-year service period, and (ii) the achievement of Harrow common stock price targets ranging from $25 - $50. The 300,363 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Baum in any market transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 762,300 shares pursuant to the terms of the Incentive Plan. Read SEC document |
| April 03, 2025 Filed Apr 8, 2025 01:54 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionPerformance Stock Unit · Derivative | 762,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-003109 · ownership.xml · derivative · entry 3 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 762,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The 762,300 shares of Harrow, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares upon vesting of performance stock units ("PSUs") granted to Mr. Baum under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on April 3, 2023. The PSUs vested on April 3, 2025 and were settled in full in shares of Harrow common stock (on a one-for-one basis) on April 7, 2025, following attainment of (i) a two-year service period, and (ii) the achievement of Harrow common stock price targets ranging from $25 - $50. The 300,363 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Baum in any market transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 762,300 shares pursuant to the terms of the Incentive Plan. F1 · derivative.exercise_date: The 762,300 shares of Harrow, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares upon vesting of performance stock units ("PSUs") granted to Mr. Baum under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on April 3, 2023. The PSUs vested on April 3, 2025 and were settled in full in shares of Harrow common stock (on a one-for-one basis) on April 7, 2025, following attainment of (i) a two-year service period, and (ii) the achievement of Harrow common stock price targets ranging from $25 - $50. The 300,363 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Baum in any market transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 762,300 shares pursuant to the terms of the Incentive Plan. F1 · derivative.expiration_date: The 762,300 shares of Harrow, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares upon vesting of performance stock units ("PSUs") granted to Mr. Baum under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on April 3, 2023. The PSUs vested on April 3, 2025 and were settled in full in shares of Harrow common stock (on a one-for-one basis) on April 7, 2025, following attainment of (i) a two-year service period, and (ii) the achievement of Harrow common stock price targets ranging from $25 - $50. The 300,363 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Baum in any market transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 762,300 shares pursuant to the terms of the Incentive Plan. Read SEC document |
| April 03, 2025 Filed Apr 8, 2025 01:54 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionCommon Stock | 762,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-003109 · ownership.xml · nonDerivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,899,825 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The 762,300 shares of Harrow, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares upon vesting of performance stock units ("PSUs") granted to Mr. Baum under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on April 3, 2023. The PSUs vested on April 3, 2025 and were settled in full in shares of Harrow common stock (on a one-for-one basis) on April 7, 2025, following attainment of (i) a two-year service period, and (ii) the achievement of Harrow common stock price targets ranging from $25 - $50. The 300,363 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Baum in any market transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 762,300 shares pursuant to the terms of the Incentive Plan. Read SEC document |
| March 22, 2024 Filed Mar 25, 2024 11:00 UTC | HARROW, INC. HROW · Entity 4740 | PurchaseCommon stock | 9,000 | $11.59 | $104,310.00 |
DisclosureSEC source: 0001493152-24-011071 · ownership.xml · nonDerivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,137,525 F1 · security: These shares were purchased in multiple transactions at a price of $11.585. The reporting person undertakes to provide to Harrow, Inc. ("Harrow"), any security holder of Harrow, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 00:29 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionRSU · Derivative | 150,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-007453 · ownership.xml · derivative · entry 3 BAUM MARK L · CIK 0001274282 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The listed acquired 150,000 shares of Harrow, Inc. ("Harrow")_common stock represent restricted stock units (RSUs") granted to Mr. Baum on February 19, 2021 under the Issuer's 2017 Stock Incentive and Awards Plan, as amended. The RSUs vested after a three-year period following the award date. 59,836 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Baum's payroll tax liability incident related to the vesting of the RSUs. Such withholding did not involve any market sales or other market transactions. F1 · derivative.exercise_date: The listed acquired 150,000 shares of Harrow, Inc. ("Harrow")_common stock represent restricted stock units (RSUs") granted to Mr. Baum on February 19, 2021 under the Issuer's 2017 Stock Incentive and Awards Plan, as amended. The RSUs vested after a three-year period following the award date. 59,836 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Baum's payroll tax liability incident related to the vesting of the RSUs. Such withholding did not involve any market sales or other market transactions. F1 · derivative.expiration_date: The listed acquired 150,000 shares of Harrow, Inc. ("Harrow")_common stock represent restricted stock units (RSUs") granted to Mr. Baum on February 19, 2021 under the Issuer's 2017 Stock Incentive and Awards Plan, as amended. The RSUs vested after a three-year period following the award date. 59,836 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Baum's payroll tax liability incident related to the vesting of the RSUs. Such withholding did not involve any market sales or other market transactions. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 00:29 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionCommon stock | 59,836 | $10.67 | $638,450.12 |
DisclosureSEC source: 0001493152-24-007453 · ownership.xml · nonDerivative · entry 2 BAUM MARK L · CIK 0001274282 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,128,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The listed acquired 150,000 shares of Harrow, Inc. ("Harrow")_common stock represent restricted stock units (RSUs") granted to Mr. Baum on February 19, 2021 under the Issuer's 2017 Stock Incentive and Awards Plan, as amended. The RSUs vested after a three-year period following the award date. 59,836 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Baum's payroll tax liability incident related to the vesting of the RSUs. Such withholding did not involve any market sales or other market transactions. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 00:29 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionCommon stock | 150,000 | $10.67 | $1,600,500.00 |
DisclosureSEC source: 0001493152-24-007453 · ownership.xml · nonDerivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,188,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 12:30 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,400 | $0.00 Strike: $7.71 | $0.00 |
DisclosureSEC source: 0001493152-24-005371 · ownership.xml · derivative · entry 2 BAUM MARK L · CIK 0001274282 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,400 shares Expires 2024-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents stock options granted to Mr. Baum on February 10, 2014 under the Issuer's 2007 Stock Incentive and Awards Plan, as amended. The stock option vested quarterly over a three-year period following the grant date. The total exercise price for the options ($118,734) was paid in cash to the Issuer by Mr. Baum. F1 · derivative.exercise_date: Represents stock options granted to Mr. Baum on February 10, 2014 under the Issuer's 2007 Stock Incentive and Awards Plan, as amended. The stock option vested quarterly over a three-year period following the grant date. The total exercise price for the options ($118,734) was paid in cash to the Issuer by Mr. Baum. Read SEC document |
| February 07, 2024 Filed Feb 8, 2024 12:30 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionCommon stock | 15,400 | $7.71 | $118,734.00 |
DisclosureSEC source: 0001493152-24-005371 · ownership.xml · nonDerivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,038,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2023 Filed Nov 16, 2023 21:45 UTC | HARROW, INC. HROW · Entity 4740 | PurchaseCommon Stock | 7,500 | $8.11 | $60,825.00 |
DisclosureSEC source: 0001493152-23-041691 · ownership.xml · nonDerivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,022,961 F1 · price: These shares were purchased in a single transaction at a price of $8.1097. Read SEC document |
| August 14, 2023 Filed Aug 15, 2023 11:30 UTC | HARROW, INC. HROW · Entity 4740 | PurchaseCommon Stock | 5,800 | $17.05 | $98,890.00 |
DisclosureSEC source: 0001493152-23-028832 · ownership.xml · nonDerivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,015,461 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.01 to $17.06, inclusive. The reporting person undertakes to provide to Harrow Health, Inc. ("Harrow"), any security holder of Harrow, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| July 18, 2023 Filed Jul 20, 2023 23:48 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionPerformance Stock Unit · Derivative | 762,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-025150 · ownership.xml · derivative · entry 3 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 762,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The 762,300 shares of Harrow Health, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares issued based on vesting of performance stock units ("PSUs") granted to Mr. Baum under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on July 23, 2021. The PSUs were settled in full (on a one-for-one basis) on July 18, 2023, following attainment of total stockholder return targets ranging from 50% - 175 % following the date of the award. The 299,968 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Baum in any transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 762,300 shares pursuant to the terms of the Incentive Plan. F1 · derivative.exercise_date: The 762,300 shares of Harrow Health, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares issued based on vesting of performance stock units ("PSUs") granted to Mr. Baum under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on July 23, 2021. The PSUs were settled in full (on a one-for-one basis) on July 18, 2023, following attainment of total stockholder return targets ranging from 50% - 175 % following the date of the award. The 299,968 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Baum in any transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 762,300 shares pursuant to the terms of the Incentive Plan. F1 · derivative.expiration_date: The 762,300 shares of Harrow Health, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares issued based on vesting of performance stock units ("PSUs") granted to Mr. Baum under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on July 23, 2021. The PSUs were settled in full (on a one-for-one basis) on July 18, 2023, following attainment of total stockholder return targets ranging from 50% - 175 % following the date of the award. The 299,968 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Baum in any transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 762,300 shares pursuant to the terms of the Incentive Plan. Read SEC document |
| July 18, 2023 Filed Jul 20, 2023 23:48 UTC | HARROW, INC. HROW · Entity 4740 | Tax withholdingCommon Stock | 299,968 | $18.23 | $5,468,416.64 |
DisclosureSEC source: 0001493152-23-025150 · ownership.xml · nonDerivative · entry 2 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,009,661 F1 · shares: The 762,300 shares of Harrow Health, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares issued based on vesting of performance stock units ("PSUs") granted to Mr. Baum under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on July 23, 2021. The PSUs were settled in full (on a one-for-one basis) on July 18, 2023, following attainment of total stockholder return targets ranging from 50% - 175 % following the date of the award. The 299,968 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Baum in any transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 762,300 shares pursuant to the terms of the Incentive Plan. Read SEC document |
| July 18, 2023 Filed Jul 20, 2023 23:48 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionCommon Stock | 762,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-23-025150 · ownership.xml · nonDerivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,309,629 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The 762,300 shares of Harrow Health, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares issued based on vesting of performance stock units ("PSUs") granted to Mr. Baum under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on July 23, 2021. The PSUs were settled in full (on a one-for-one basis) on July 18, 2023, following attainment of total stockholder return targets ranging from 50% - 175 % following the date of the award. The 299,968 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Baum in any transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 762,300 shares pursuant to the terms of the Incentive Plan. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 23:54 UTC | HARROW, INC. HROW · Entity 4740 | GrantRestricted Stock Unit · Derivative | 762,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-010886 · ownership.xml · derivative · entry 4 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 762,300 Underlying: Common Stock · 762,300 shares Expires 2028-04-03 F3 · derivative.exercise_price: Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2017 Stock Incentive and Awards Plan, as amended (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. The vesting of the PSUs (granted in lieu of service only stock option and restricted stock unit awards) require (i) a minimum of a two-year service period, and (ii) the achievement and maintenance of Harrow common stock price targets of $25 (causing the vesting of 108,900 PSU shares), $35 (causing the vesting of 163,350 PSU shares), $45 (causing the vesting of 217,800 PSU shares), $50 (causing the vesting of 272,250 PSU shares). F3 · derivative.exercise_date: Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2017 Stock Incentive and Awards Plan, as amended (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. The vesting of the PSUs (granted in lieu of service only stock option and restricted stock unit awards) require (i) a minimum of a two-year service period, and (ii) the achievement and maintenance of Harrow common stock price targets of $25 (causing the vesting of 108,900 PSU shares), $35 (causing the vesting of 163,350 PSU shares), $45 (causing the vesting of 217,800 PSU shares), $50 (causing the vesting of 272,250 PSU shares). Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 23:54 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionStock Option (Right to Buy) · Derivative | 180,000 | $0.00 Strike: $8.99 | $0.00 |
DisclosureSEC source: 0001493152-23-010886 · ownership.xml · derivative · entry 3 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 180,000 shares Expires 2023-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option was granted on May 2, 2013 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period, according to a quarterly vesting schedule following its grant date. The stock option had an expiration date of May 2, 2023. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 23:54 UTC | HARROW, INC. HROW · Entity 4740 | Tax withholdingCommon Stock | 117,633 | $20.97 | $2,466,764.01 |
DisclosureSEC source: 0001493152-23-010886 · ownership.xml · nonDerivative · entry 2 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,547,329 F1 · security: Shares withheld to satisfy the exercise price and tax liability incident to the exercise of the stock option. Such withholding did not involve any market sales or other market transactions. F1 · shares: Shares withheld to satisfy the exercise price and tax liability incident to the exercise of the stock option. Such withholding did not involve any market sales or other market transactions. Read SEC document |
| April 03, 2023 Filed Apr 4, 2023 23:54 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionCommon Stock | 180,000 | $8.99 | $1,618,200.00 |
DisclosureSEC source: 0001493152-23-010886 · ownership.xml · nonDerivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,664,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Shares withheld to satisfy the exercise price and tax liability incident to the exercise of the stock option. Such withholding did not involve any market sales or other market transactions. Read SEC document |
| January 02, 2023 Filed Jan 4, 2023 02:52 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionRestricted Stock Unit · Derivative | 88,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-000190 · ownership.xml · derivative · entry 3 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 88,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The listed Acquired (as described in the table above) 88,000 shares of Harrow Health, Inc. ("Harrow") common stock represent restricted stock units ("RSUs") granted to Mr. Baum under the Issuer's 2017 Stock Incentive and Awards Plan on January 2, 2020. The RSUs, which vested in full on January 2, 2023, the third-year anniversary of the grant of the same, settled as one share of common stock for each RSU. The listed Disposed (as described in the table above) 35,179 shares of Harrow common stock were not sold by Mr. Baum in any transaction; rather, they were shares of Harrow common stock withheld, by the Company, from the same aforementioned 88,000 RSU share issuance for payroll tax purposes only. F1 · derivative.exercise_date: The listed Acquired (as described in the table above) 88,000 shares of Harrow Health, Inc. ("Harrow") common stock represent restricted stock units ("RSUs") granted to Mr. Baum under the Issuer's 2017 Stock Incentive and Awards Plan on January 2, 2020. The RSUs, which vested in full on January 2, 2023, the third-year anniversary of the grant of the same, settled as one share of common stock for each RSU. The listed Disposed (as described in the table above) 35,179 shares of Harrow common stock were not sold by Mr. Baum in any transaction; rather, they were shares of Harrow common stock withheld, by the Company, from the same aforementioned 88,000 RSU share issuance for payroll tax purposes only. F1 · derivative.expiration_date: The listed Acquired (as described in the table above) 88,000 shares of Harrow Health, Inc. ("Harrow") common stock represent restricted stock units ("RSUs") granted to Mr. Baum under the Issuer's 2017 Stock Incentive and Awards Plan on January 2, 2020. The RSUs, which vested in full on January 2, 2023, the third-year anniversary of the grant of the same, settled as one share of common stock for each RSU. The listed Disposed (as described in the table above) 35,179 shares of Harrow common stock were not sold by Mr. Baum in any transaction; rather, they were shares of Harrow common stock withheld, by the Company, from the same aforementioned 88,000 RSU share issuance for payroll tax purposes only. Read SEC document |
| January 02, 2023 Filed Jan 4, 2023 02:52 UTC | HARROW, INC. HROW · Entity 4740 | Tax withholdingCommon Stock | 35,179 | $14.76 | $519,242.04 |
DisclosureSEC source: 0001493152-23-000190 · ownership.xml · nonDerivative · entry 2 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,484,962 F1 · security: The listed Acquired (as described in the table above) 88,000 shares of Harrow Health, Inc. ("Harrow") common stock represent restricted stock units ("RSUs") granted to Mr. Baum under the Issuer's 2017 Stock Incentive and Awards Plan on January 2, 2020. The RSUs, which vested in full on January 2, 2023, the third-year anniversary of the grant of the same, settled as one share of common stock for each RSU. The listed Disposed (as described in the table above) 35,179 shares of Harrow common stock were not sold by Mr. Baum in any transaction; rather, they were shares of Harrow common stock withheld, by the Company, from the same aforementioned 88,000 RSU share issuance for payroll tax purposes only. Read SEC document |
| January 02, 2023 Filed Jan 4, 2023 02:52 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionCommon Stock | 88,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-23-000190 · ownership.xml · nonDerivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,520,141 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The listed Acquired (as described in the table above) 88,000 shares of Harrow Health, Inc. ("Harrow") common stock represent restricted stock units ("RSUs") granted to Mr. Baum under the Issuer's 2017 Stock Incentive and Awards Plan on January 2, 2020. The RSUs, which vested in full on January 2, 2023, the third-year anniversary of the grant of the same, settled as one share of common stock for each RSU. The listed Disposed (as described in the table above) 35,179 shares of Harrow common stock were not sold by Mr. Baum in any transaction; rather, they were shares of Harrow common stock withheld, by the Company, from the same aforementioned 88,000 RSU share issuance for payroll tax purposes only. F1 · price: The listed Acquired (as described in the table above) 88,000 shares of Harrow Health, Inc. ("Harrow") common stock represent restricted stock units ("RSUs") granted to Mr. Baum under the Issuer's 2017 Stock Incentive and Awards Plan on January 2, 2020. The RSUs, which vested in full on January 2, 2023, the third-year anniversary of the grant of the same, settled as one share of common stock for each RSU. The listed Disposed (as described in the table above) 35,179 shares of Harrow common stock were not sold by Mr. Baum in any transaction; rather, they were shares of Harrow common stock withheld, by the Company, from the same aforementioned 88,000 RSU share issuance for payroll tax purposes only. Read SEC document |
| December 22, 2022 Filed Dec 23, 2022 12:03 UTC | HARROW, INC. HROW · Entity 4740 | PurchaseCommon Stock | 25,000 | $13.39 | $334,750.00 |
DisclosureSEC source: 0001493152-22-036396 · ownership.xml · nonDerivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,432,141 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.34 to $13.42, inclusive. The reporting person undertakes to provide to Harrow Health, Inc. ("Harrow"), any security holder of Harrow, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 20, 2022 Filed Jan 22, 2022 01:45 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionStock Option (Right to buy) · Derivative | 125,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001493152-22-002006 · ownership.xml · derivative · entry 3 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires 2022-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents stock options granted to Mr. Baum on January 25, 2012 under the Issuer's 2007 Stock Incentive and Awards Plan, as amended. The stock option vested 1/12 on a monthly basis over the one year period following the grant date. The Company withheld a total of 71,406 shares of common stock from issuance to Mr. Baum: (i) 36,014 shares withheld as consideration for the cashless exercise of the option; and (ii) an additional 35,392 shares withheld for payroll tax purposes. F1 · derivative.exercise_date: Represents stock options granted to Mr. Baum on January 25, 2012 under the Issuer's 2007 Stock Incentive and Awards Plan, as amended. The stock option vested 1/12 on a monthly basis over the one year period following the grant date. The Company withheld a total of 71,406 shares of common stock from issuance to Mr. Baum: (i) 36,014 shares withheld as consideration for the cashless exercise of the option; and (ii) an additional 35,392 shares withheld for payroll tax purposes. Read SEC document |
| January 20, 2022 Filed Jan 22, 2022 01:45 UTC | HARROW, INC. HROW · Entity 4740 | Tax withholdingCommon Stock | 71,406 | $8.33 | $594,811.98 |
DisclosureSEC source: 0001493152-22-002006 · ownership.xml · nonDerivative · entry 2 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,407,141 F1 · security: Represents stock options granted to Mr. Baum on January 25, 2012 under the Issuer's 2007 Stock Incentive and Awards Plan, as amended. The stock option vested 1/12 on a monthly basis over the one year period following the grant date. The Company withheld a total of 71,406 shares of common stock from issuance to Mr. Baum: (i) 36,014 shares withheld as consideration for the cashless exercise of the option; and (ii) an additional 35,392 shares withheld for payroll tax purposes. Read SEC document |
| January 20, 2022 Filed Jan 22, 2022 01:45 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionCommon Stock | 125,000 | $2.40 | $300,000.00 |
DisclosureSEC source: 0001493152-22-002006 · ownership.xml · nonDerivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,478,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents stock options granted to Mr. Baum on January 25, 2012 under the Issuer's 2007 Stock Incentive and Awards Plan, as amended. The stock option vested 1/12 on a monthly basis over the one year period following the grant date. The Company withheld a total of 71,406 shares of common stock from issuance to Mr. Baum: (i) 36,014 shares withheld as consideration for the cashless exercise of the option; and (ii) an additional 35,392 shares withheld for payroll tax purposes. Read SEC document |
| July 23, 2021 Filed Jul 23, 2021 21:44 UTC | HARROW, INC. HROW · Entity 4740 | GrantRestricted Stock Unit · Derivative | 762,301 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-017686 · ownership.xml · derivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 762,301 Underlying: Common Stock · 762,301 shares Expires 2026-07-23 F1 · derivative.exercise_price: Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2017 Stock Incentive and Awards Plan, as amended (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. Vesting of the PSUs requires a minimum of a two-year service period and achievement of pre-determined total stockholder return-based performance targets ranging from a 50% - 250% increase during the term of the PSUs. F1 · derivative.exercise_date: Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2017 Stock Incentive and Awards Plan, as amended (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. Vesting of the PSUs requires a minimum of a two-year service period and achievement of pre-determined total stockholder return-based performance targets ranging from a 50% - 250% increase during the term of the PSUs. Read SEC document |
| April 25, 2021 Filed Apr 27, 2021 21:29 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionRestricked Stock Unit · Derivative | 850,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-009872 · ownership.xml · derivative · entry 3 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 850,000 shares Expires 2021-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents remaining performance-based restricted stock units ("RSUs") granted to Mr. Baum under the Issuer's 2007 Stock Incentive and Awards Plan on April 25, 2016. The RSUs settled in one share of common stock for each RSU. 334,129 shares of common stock were withheld from issuance to Mr. Baum for payroll tax purposes. Read SEC document |
| April 25, 2021 Filed Apr 27, 2021 21:29 UTC | HARROW, INC. HROW · Entity 4740 | Tax withholdingCommon Stock | 334,129 | $8.26 | $2,759,905.54 |
DisclosureSEC source: 0001493152-21-009872 · ownership.xml · nonDerivative · entry 2 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,353,547 F1 · security: Represents remaining performance-based restricted stock units ("RSUs") granted to Mr. Baum under the Issuer's 2007 Stock Incentive and Awards Plan on April 25, 2016. The RSUs settled in one share of common stock for each RSU. 334,129 shares of common stock were withheld from issuance to Mr. Baum for payroll tax purposes. Read SEC document |
| April 25, 2021 Filed Apr 27, 2021 21:29 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionCommon Stock | 850,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-009872 · ownership.xml · nonDerivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,687,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents remaining performance-based restricted stock units ("RSUs") granted to Mr. Baum under the Issuer's 2007 Stock Incentive and Awards Plan on April 25, 2016. The RSUs settled in one share of common stock for each RSU. 334,129 shares of common stock were withheld from issuance to Mr. Baum for payroll tax purposes. Read SEC document |
| February 25, 2021 Filed Feb 27, 2021 01:14 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionRestricted Stock Unit · Derivative | 200,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-005005 · ownership.xml · derivative · entry 2 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850,000 Underlying: Common Stock · 200,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents performance-based restricted stock units ("RSUs") granted to Mr. Baum under the Issuer's 2007 Stock Incentive and Awards Plan on April 25, 2016. The RSUs settle in one share of common stock for each RSU and provide for accelerated vesting based on pre-determined stock price-based performance targets during the term of the RSUs. F1 · derivative.exercise_date: Represents performance-based restricted stock units ("RSUs") granted to Mr. Baum under the Issuer's 2007 Stock Incentive and Awards Plan on April 25, 2016. The RSUs settle in one share of common stock for each RSU and provide for accelerated vesting based on pre-determined stock price-based performance targets during the term of the RSUs. F1 · derivative.expiration_date: Represents performance-based restricted stock units ("RSUs") granted to Mr. Baum under the Issuer's 2007 Stock Incentive and Awards Plan on April 25, 2016. The RSUs settle in one share of common stock for each RSU and provide for accelerated vesting based on pre-determined stock price-based performance targets during the term of the RSUs. Read SEC document |
| February 25, 2021 Filed Feb 27, 2021 01:14 UTC | HARROW, INC. HROW · Entity 4740 | Exercise / conversionCommon Stock | 200,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-21-005005 · ownership.xml · nonDerivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 837,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents performance-based restricted stock units ("RSUs") granted to Mr. Baum under the Issuer's 2007 Stock Incentive and Awards Plan on April 25, 2016. The RSUs settle in one share of common stock for each RSU and provide for accelerated vesting based on pre-determined stock price-based performance targets during the term of the RSUs. F1 · price: Represents performance-based restricted stock units ("RSUs") granted to Mr. Baum under the Issuer's 2007 Stock Incentive and Awards Plan on April 25, 2016. The RSUs settle in one share of common stock for each RSU and provide for accelerated vesting based on pre-determined stock price-based performance targets during the term of the RSUs. Read SEC document |
| February 19, 2021 Filed Feb 24, 2021 01:14 UTC | HARROW, INC. HROW · Entity 4740 | GrantRestricted Stock Unit · Derivative | 150,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-004654 · ownership.xml · derivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2024-02-19 F1 · derivative.exercise_date: Represents restricted stock units ("RSUs") granted under the Issuer's 2017 Stock Incentive and Awards Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer upon the vesting and settlement of the RSU. The RSUs vest and settle in full on the third anniversary of the date of grant. Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 22:05 UTC | HARROW, INC. HROW · Entity 4740 | GrantEmployee Stock Option - Right to Buy · Derivative | 600,000 | $0.00 Strike: $7.87 | $0.00 |
DisclosureSEC source: 0001493152-20-010785 · ownership.xml · derivative · entry 2 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2025-07-31 F1 · kind: The two reported transactions involve an amendment of an outstanding option to extend the term of the option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on July 31, 2015. The option provides for vesting in five installments based on the satisfaction of certain stock-price based performance targets during the term of such option. F1 · derivative.exercise_date: The two reported transactions involve an amendment of an outstanding option to extend the term of the option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on July 31, 2015. The option provides for vesting in five installments based on the satisfaction of certain stock-price based performance targets during the term of such option. Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 22:05 UTC | HARROW, INC. HROW · Entity 4740 | Disposition to issuerEmployee Stock Option - Right to Buy · Derivative | 600,000 | $0.00 Strike: $7.87 | $0.00 |
DisclosureSEC source: 0001493152-20-010785 · ownership.xml · derivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 600,000 shares Expires 2020-07-31 F1 · kind: The two reported transactions involve an amendment of an outstanding option to extend the term of the option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on July 31, 2015. The option provides for vesting in five installments based on the satisfaction of certain stock-price based performance targets during the term of such option. F1 · derivative.exercise_date: The two reported transactions involve an amendment of an outstanding option to extend the term of the option, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on July 31, 2015. The option provides for vesting in five installments based on the satisfaction of certain stock-price based performance targets during the term of such option. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 20:58 UTC | Eton Pharmaceuticals, Inc. ETON · Entity 4598 | GrantStock Option (Right to buy) · Derivative | 27,400 | $0.00 Strike: $3.58 | $0.00 |
DisclosureSEC source: 0001493152-20-004062 · ownership.xml · derivative · entry 1 BAUM MARK L · CIK 0001274282 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,400 Underlying: Common Stock · 27,400 shares Expires 2030-03-11 F1 · derivative.exercise_date: The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on March 12, 2021. Read SEC document |
| January 02, 2020 Filed Jan 7, 2020 00:46 UTC | HARROW, INC. HROW · Entity 4740 | GrantRestricted Stock Unit · Derivative | 88,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-000270 · ownership.xml · derivative · entry 2 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,000 Underlying: Common Stock · 88,000 shares Expires 2023-01-02 F2 · derivative.exercise_date: Represents restricted stock units ("RSUs") granted under the Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer upon the vesting and settlement of the RSU. The RSUs vest and settle in full on the third anniversary of the date of grant. Read SEC document |
| January 02, 2020 Filed Jan 7, 2020 00:46 UTC | HARROW, INC. HROW · Entity 4740 | GrantOption - Right to Buy · Derivative | 217,500 | $0.00 Strike: $7.30 | $0.00 |
DisclosureSEC source: 0001493152-20-000270 · ownership.xml · derivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,500 Underlying: Common Stock · 217,500 shares Expires 2030-01-02 F1 · derivative.exercise_date: Represents stock options granted under the Issuer's 2017 Stock Incentive and Awards Plan (the "Plan"). The stock options vest in equal quarterly installments over a three-year period. Read SEC document |
| January 02, 2020 Filed Jan 7, 2020 02:41 UTC Amendment | HARROW, INC. HROW · Entity 4740 | GrantRestricted Stock Unit · Derivative | 88,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-000279 · ownership.xml · derivative · entry 2 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,000 Underlying: Common Stock · 88,000 shares Expires 2023-01-02 F2 · derivative.exercise_date: Represents restricted stock units ("RSUs") granted under the Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer upon the vesting and settlement of the RSU. The RSUs vest and settle in full on the third anniversary of the date of grant. Read SEC document |
| January 02, 2020 Filed Jan 7, 2020 02:41 UTC Amendment | HARROW, INC. HROW · Entity 4740 | GrantOption - Right to Buy · Derivative | 217,500 | $0.00 Strike: $7.30 | $0.00 |
DisclosureSEC source: 0001493152-20-000279 · ownership.xml · derivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,500 Underlying: Common Stock · 217,500 shares Expires 2030-01-02 F1 · derivative.exercise_date: Represents stock options granted under the Issuer's 2017 Stock Incentive and Awards Plan (the "Plan"). The stock options vest in equal quarterly installments over a three-year period. Read SEC document |
| November 22, 2019 Filed Nov 25, 2019 21:12 UTC | HARROW, INC. HROW · Entity 4740 | OtherPurchase Warrant · Derivative | 156,000 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001493152-19-018350 · ownership.xml · derivative · entry 2 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 156,000 shares Expires 2019-12-23 F2 · security: On November 22, 2019, the Beadore Trust assigned the Purchase Warrants to the Four Tree Trust. Read SEC document |
| November 22, 2019 Filed Nov 25, 2019 21:12 UTC | HARROW, INC. HROW · Entity 4740 | OtherCommon Stock | 156,000 | $1.79 | $279,240.00 |
DisclosureSEC source: 0001493152-19-018350 · ownership.xml · nonDerivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 598,126 F1 · ownership.nature: Total number of shares beneficially held by the Four Tree Trust dated June 3, 2019 (the "Four Tree Trust"), a trust through which Mr. Baum has voting and investment control over the securities. Mr. Baum, individually, and the Beadore Trust dated March 20, 2015 (the "Beadore Trust") assigned 442,126 shares of the Company's common stock to the Four Tree Trust. Read SEC document |
| February 20, 2019 Filed Mar 8, 2019 21:32 UTC | Eton Pharmaceuticals, Inc. ETON · Entity 4598 | GrantStock option (right to buy) · Derivative | 12,500 | $0.00 Strike: $7.31 | $0.00 |
DisclosureSEC source: 0001209191-19-018109 · doc4.xml · derivative · entry 1 BAUM MARK L · CIK 0001274282 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2029-02-19 F1 · derivative.exercise_date: The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on February 20, 2020. Read SEC document |
| February 19, 2019 Filed Feb 22, 2019 00:44 UTC | HARROW, INC. HROW · Entity 4740 | GrantOption - Right to Buy · Derivative | 150,000 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0001493152-19-002375 · ownership.xml · derivative · entry 1 BAUM MARK L · CIK 0001274282 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2029-02-19 F1 · derivative.exercise_date: Represents stock options granted under the Issuer's 2017 Stock Incentive and Awards Plan. The stock options vest in equal quarterly installments over a three year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.